Paper Details
- Home
- Paper Details
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review.
Author: DestereAlexandre, DriciMilou-Daniel, GérardAlexandre O, LavrutThibaud, MerinoDiane, RocherFanny, ViardDelphine
Original Abstract of the Article :
Drug-induced cardiotoxicity is a primary concern in both drug development and clinical practice. Although the heart is not a common target for adverse drug reactions, some drugs still cause various adverse cardiac events, with sometimes severe consequences. Direct cardiac toxicity encompasses functi...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.therap.2023.10.008
データ提供:米国国立医学図書館(NLM)
The Silent Threat: Drug-Induced Cardiac Toxicity
The world of medicine is a double-edged sword. While medications offer relief and treatment for a wide range of ailments, some can have unintended consequences, including damage to the heart. This study delves into the complex issue of drug-induced cardiac toxicity, exploring the various drugs that can affect the heart, the underlying mechanisms, and the strategies for mitigating this risk. Like a desert traveler navigating treacherous terrain, researchers are working to understand and manage the potential for drugs to harm the heart.
A Hidden Danger: Cardiac Toxicity Beyond Cardiovascular Drugs
This study reveals that cardiac toxicity is not limited to cardiovascular medications. A wide range of drugs, including anticancer drugs, antipsychotics, antibiotics, and even certain antidepressants, can have adverse effects on the heart. Researchers highlight the various mechanisms by which these drugs can cause cardiac damage, including disturbances in ionic processes, mitochondrial dysfunction, and hypercoagulability. This underscores the need for vigilant monitoring and careful evaluation of the potential for drug-induced cardiac toxicity.
Safeguarding the Heart: Strategies for Mitigation and Prevention
The study emphasizes the importance of multi-stage evaluation guidelines for drug development, following International Council for Harmonisation (ICH) guidelines for in vitro and in vivo testing. However, it acknowledges that post-marketing surveillance is equally crucial, as some cardiotoxic drugs may escape initial scrutiny. This study calls for a collaborative approach between physicians and cardiologists to identify, manage, and prevent drug-induced cardiac adverse events. As a researcher, I'm always mindful of the potential risks associated with medications and the importance of patient safety. This study underscores the need for continuous vigilance and a multidisciplinary approach to minimize the harmful effects of drugs on the heart.
Dr. Camel's Conclusion
Drug-induced cardiac toxicity is a significant concern in both drug development and clinical practice. This study highlights the diverse range of drugs that can affect the heart and the need for careful evaluation, vigilant monitoring, and a collaborative approach to mitigate and prevent cardiac adverse events. The study reinforces the importance of patient safety and the need for continuous research to advance our understanding of drug-induced cardiac toxicity.
Date :
- Date Completed n.d.
- Date Revised 2023-11-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.